clenbuterol has been researched along with Non-ST-Elevation Myocardial Infarction in 1 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quinley, KE | 1 |
| Chen, HY | 1 |
| Yang, HS | 1 |
| Lynch, KL | 1 |
| Olson, KR | 1 |
1 review available for clenbuterol and Non-ST-Elevation Myocardial Infarction
| Article | Year |
|---|---|
Clenbuterol causing non-ST-segment elevation myocardial infarction in a teenage female desiring to lose weight: case and brief literature review.
Topics: Adolescent; Adrenergic beta-Agonists; Anti-Obesity Agents; Clenbuterol; Female; Humans; Non-ST Eleva | 2016 |